Dog /

Breed profile · FDA CVM July 2026 extract

Boerboel adverse-event record

Adverse-event filings for Boerboel (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#385 of 510
by report volume (all breeds)
17
FDA CVM reports on file
5.9%
death-coded share of reports
6
Vomiting - top reaction

How the 17 reports break down

By recorded gender -- every report on file for Boerboel, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 3 2.25 1.5 0.75 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Boerboel drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Boerboel ranks #384 of 510 by total reports (17). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#384
This breed, reports of 510

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Boerboel has 17 reports now versus 17 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Boerboel changes

Total Reports

17

Low report volume

Deaths Reported

1

of 17 reports

Death-coded share of reports

5.9%

5.9% death-coded

Avg Age at Report

3.6 yr

55.8 kg avg weight

Death-Coded Outcome Share

Boerboel death-coded reports 5.9%
Cross-breed median

5.9% of 17 boerboel reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 55.8 kg (123.0 lbs)

Top Reported Reactions

Vomiting 6
Lack of efficacy (endoparasite) - heartworm 3
Lack of efficacy (ectoparasite) - flea 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Loose stool 1

Most Referenced Drugs

Milbemycin Oxime + Spinosad 6
Ivermectin + Pyrantel As Pamoate Salt 5
Grapiprant 2
Fluralaner Chew Tablets 2
Fluralaner 13.64% 12-Week Chew 2

Outcome Breakdown

Recovered/Normal
6 (35.3%)
Ongoing
5 (29.4%)
Outcome Unknown
5 (29.4%)
Died
1 (5.9%)

Gender Distribution

Male 10 (58.8%)
Female 7 (41.2%)

Reports by Year

Year Reports Trend
2013 1
2017 1
2018 2
2019 1
2020 2
2021 2
2022 2
2023 1
2024 2
2025 3

Boerboel: sparse FDA adverse-event cohort

Signature read: 17 reports place Boerboel in the lower third of breed filing volume (#385 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Boerboel sits at #385 of 510 by report volume among all breeds and #249 of 298 among dog breeds, with 17 reports and 1 (5.9%) death-coded. Mean age at report: 3.6 years, average weight 55.8 kg (123.0 lbs).

Top reported signs: Vomiting (6), Lack of efficacy (endoparasite) - heartworm (3), Lack of efficacy (ectoparasite) - flea (2). Most-referenced drug: Milbemycin Oxime + Spinosad (6 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (5) and Grapiprant (2).

Outcome coding on 17 status-recorded reports is dominated by Recovered/Normal (35.3%). Annual submissions ranged 1-2,025 across 10 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Sparse-volume peer sets for Boerboel drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Boerboel?
There are 17 adverse event reports involving Boerboel in the FDA database, of which 1 were death-coded (5.9% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Boerboel ranks #385 of 510 by report volume among all breeds PlainBreed indexes (#249 of 298 among dog breeds).
Where does Boerboel sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Boerboel is #385 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #249 of 298. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Boerboel?
The most commonly reported adverse reactions for Boerboel are Vomiting (6 reports), Lack of efficacy (endoparasite) - heartworm (3 reports), Lack of efficacy (ectoparasite) - flea (2 reports), Lethargy (see also Central nervous system depression in 'Neurological') (2 reports), Loose stool (1 reports).
What drugs are most frequently associated with Boerboel adverse events?
The drugs most frequently referenced in Boerboel adverse event reports are Milbemycin Oxime + Spinosad (6 reports), Ivermectin + Pyrantel As Pamoate Salt (5 reports), Grapiprant (2 reports), Fluralaner Chew Tablets (2 reports), Fluralaner 13.64% 12-Week Chew (2 reports).
What is the average age of Boerboel in adverse event reports?
The average age of Boerboel at the time of adverse event reports is 3.6 years, with an average weight of 55.8 kg (123.0 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Boerboel (Dog), extract as of July 2026 extract. 17 reports · 1 death-coded (5.9% of reports, not a mortality rate) · #385 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →